Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Ensem Therapeutics
Centre Oscar Lambret
Hoffmann-La Roche
Pfizer
Università Cattolica di Milano
Eli Lilly and Company
ViroMissile, Inc.
Cancer Research UK
Sichuan Enray Pharmaceutical Sciences Company
Pfizer
Duke University
AstraZeneca
Pfizer
Tizona Therapeutics, Inc
The First Affiliated Hospital of Xiamen University
Dana-Farber Cancer Institute
University of California, San Diego
University of Arizona
Adaptimmune
University of California, San Diego
Georgetown University
University of California, Davis
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
University Health Network, Toronto
AgonOx, Inc.
M.D. Anderson Cancer Center
Medical University of South Carolina
Eli Lilly and Company
Novartis
Universidad de Granada
Brigham and Women's Hospital
Var2 Pharmaceuticals
OncoNano Medicine, Inc.
Institut de Cancérologie de Lorraine
Calico Life Sciences LLC
GlaxoSmithKline
Memorial Sloan Kettering Cancer Center
Children's Hospital of Philadelphia
Cancer Research UK
Children's Hospital of Philadelphia
Bayer
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Eli Lilly and Company
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
BioAtla, Inc.
AbbVie